# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Multi-Theatre Deal More than Doubles IMAX Footprint in Growing Filipino Market
Benchmark analyst Mike Hickey reiterates Imax (NYSE:IMAX) with a Buy and maintains $22 price target.
Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $22 price target.
Barrington Research analyst James Goss maintains Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.
Imax reported quarterly earnings of 15 cents per share which beat the analyst consensus estimate of 10 cents by 50%. Quarterly ...
Imax (NYSE:IMAX) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.10 by 50 percen...
New Collaboration Brings State-of-the Art IMAX with Laser to Thriving Turkish Cinema Market for First TimeNEW YORK and ISTANBUL...
Barrington Research analyst James Goss maintains Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.